These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 2669797)
1. Bone marrow cells from young and old New Zealand black mice can reconstitute B lymphocytes in severe combined immunodeficient recipients. Dorshkind K; Yoshida S; Gershwin ME J Autoimmun; 1989 Apr; 2(2):173-86. PubMed ID: 2669797 [TBL] [Abstract][Full Text] [Related]
2. Abnormalities of B lineage cells are demonstrable in long term lymphoid bone marrow cultures of New Zealand black mice. Yoshida S; Dorshkind K; Bearer E; Castles JJ; Ahmed A; Gershwin ME J Immunol; 1987 Sep; 139(5):1454-8. PubMed ID: 3497971 [TBL] [Abstract][Full Text] [Related]
3. B220- bone marrow progenitor cells from New Zealand black autoimmune mice exhibit an age-associated decline in Pre-B and B-cell generation. Merchant MS; Garvy BA; Riley RL Blood; 1995 Apr; 85(7):1850-7. PubMed ID: 7535590 [TBL] [Abstract][Full Text] [Related]
4. Studies of congenitally immunologically mutant New Zealand mice. IX. Age-related microenvironmental effects on autoantibody production in NZB and NZB.Xid mice studied by transplantation. Bray KR; Gershwin ME; Skelly RR; Ahmed A; Kincade PW J Immunol; 1984 Jun; 132(6):2913-8. PubMed ID: 6373922 [TBL] [Abstract][Full Text] [Related]
5. Similar in vivo expansion of B cells from normal DBA/2 and autoimmune NZB mice in xid recipients. Klinman DM; Steinberg AD J Immunol; 1987 Oct; 139(7):2284-9. PubMed ID: 3498756 [TBL] [Abstract][Full Text] [Related]
6. Autoantibodies inhibit interleukin-7-mediated proliferation and are associated with the age-dependent loss of pre-B cells in autoimmune New Zealand Black Mice. Merchant MS; Garvy BA; Riley RL Blood; 1996 Apr; 87(8):3289-96. PubMed ID: 8605345 [TBL] [Abstract][Full Text] [Related]
7. B lymphocyte lineage cells in newborn and very young NZB mice: evidence for regulatory disorders affecting B cell formation. Jyonouchi H; Kincade PW; Good RA; Gershwin ME J Immunol; 1983 Nov; 131(5):2219-25. PubMed ID: 6605377 [TBL] [Abstract][Full Text] [Related]
8. Study of congenitally immunologic mutant New Zealand mice. V. B cell function of NZB-Xid mice. Ohsugi Y; Gershwin ME; Ahmed A J Immunogenet; 1981 Apr; 8(2):129-37. PubMed ID: 6971904 [TBL] [Abstract][Full Text] [Related]
9. B cell deficiency progresses with lineage maturation in nude.X-linked immunodeficient mice B cell deficiency progresses with lineage maturation. Chung HY; Dong Z; Wortis HH J Immunol; 1992 Dec; 149(11):3456-62. PubMed ID: 1385525 [TBL] [Abstract][Full Text] [Related]
10. Comparison of response to stem cell differentiation signals between normal and autoimmune mouse strains. Raveche ES; Chused TM; Steinberg AD; Laskin CA; Edison LJ; Tjio JH J Immunol; 1985 Feb; 134(2):865-71. PubMed ID: 3880791 [TBL] [Abstract][Full Text] [Related]
11. Transfer of anti-DNA-producing B cells from NZB to unmanipulated xid recipients: effects of age, sex, and environment. Ishigatsubo Y; Klinman DM; Steinberg AD Clin Immunol Immunopathol; 1987 Nov; 45(2):244-51. PubMed ID: 3499276 [TBL] [Abstract][Full Text] [Related]
12. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. Hayakawa K; Hardy RR; Parks DR; Herzenberg LA J Exp Med; 1983 Jan; 157(1):202-18. PubMed ID: 6600267 [TBL] [Abstract][Full Text] [Related]
13. Full reconstitution of the immune deficiency in scid mice with normal stem cells requires low-dose irradiation of the recipients. Fulop GM; Phillips RA J Immunol; 1986 Jun; 136(12):4438-43. PubMed ID: 3519770 [TBL] [Abstract][Full Text] [Related]
14. Characterization of B lymphocyte lineage progenitor cells from mice with severe combined immune deficiency disease (SCID) made possible by long term culture. Witte PL; Burrows PD; Kincade PW; Cooper MD J Immunol; 1987 Apr; 138(8):2698-705. PubMed ID: 3104473 [TBL] [Abstract][Full Text] [Related]
15. Use of scid mice to identify and quantitate lymphoid-restricted stem cells in long-term bone marrow cultures. Fulop GM; Phillips RA Blood; 1989 Oct; 74(5):1537-44. PubMed ID: 2571370 [TBL] [Abstract][Full Text] [Related]
16. Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice. Morton JI; Siegel BV Proc Natl Acad Sci U S A; 1974 Jun; 71(6):2162-5. PubMed ID: 4601580 [TBL] [Abstract][Full Text] [Related]
17. CD3+ T cells in severe combined immunodeficiency (scid) mice. II. Transplantation of dm2 lymphoid cells into semi-allogeneic scid mice. Rudolphi A; Spiess S; Conradt P; Claesson MH; Reimann J Eur J Immunol; 1991 Jul; 21(7):1591-600. PubMed ID: 1829409 [TBL] [Abstract][Full Text] [Related]
18. Modulation of B-cell abnormalities in lupus-prone (NZB x NZW)F1 mice by normal bone marrow-derived B-lineage cells. Shao DZ; Yamada S; Hirayama F; Hirano H; Ono S; Hamaoka T Immunology; 1995 May; 85(1):16-25. PubMed ID: 7635516 [TBL] [Abstract][Full Text] [Related]
19. Induction of erythrocyte autoantibodies in NZB mice: spectrotype and relationship with the Xid gene. Bray KR; Gershwin ME; Castles JJ; Ohsugi Y Exp Clin Immunogenet; 1984; 1(2):83-9. PubMed ID: 6400995 [TBL] [Abstract][Full Text] [Related]
20. Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA. Steinberg BJ; Smathers PA; Frederiksen K; Steinberg AD J Clin Invest; 1982 Sep; 70(3):587-97. PubMed ID: 6980900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]